IPC, incidental prostate cancer; PSA, prostate-specific antigen; HALP, hemoglobin-albumin-lymphocyte-platelet; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; OR, odds ratio; CI, confidence interval. This evidence concerns the gene NAT10 and Familial prostate cancer.